SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly shares are experiencing volatility as investors react to competitive data in the GLP-1 sector and positive clinical trial readouts for the company's oncology pipeline. While the community remains divided over the sustainability of its premium valuation, bullish sentiment persists around the anticipated regulatory approval of its oral obesity therapy.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing extreme volatility and heavy investor interest following its recent public debut, driven by its specialized focus on AI-driven autonomous drone software already deployed in active combat zones. Market participants are actively debating the stock's potential for a massive short-term run due to its micro-float structure, with discussions polarized between excitement over its defense-tech relevance and skepticism regarding its early-stage revenue and valuation.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is facing significant volatility ahead of its upcoming earnings report, with the community actively debating whether the recent share price decline presents a compelling buying opportunity or a signal of broader weakness. Investors are closely monitoring how the company's copper and optical interconnect technologies will hold up against evolving hyperscaler demands and competitive pressures from peers.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as investors digest a series of strategic pivots, including the acquisition of parking app SpotHero and the launch of 'Uber Autonomous Solutions' to court robotaxi developers. While some in the community express skepticism over heavy R&D spending and long-term viability, others view these movescoupled with significant insider buying by the CFOas a strong signal that the company is effectively positioning itself as the central, asset-light marketplace for future autonomous mobility.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining attention as investors react to long-term clinical data published in JAMA Neurology, which reinforces the efficacy and durability of Briumvi in treating relapsing multiple sclerosis. The community remains focused on the company's revenue growth trajectory, potential for a buyout, and the strategic impact of its new national awareness campaign.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently a focal point for investors as it approaches critical mid-year regulatory deadlines, with community discourse heavily influenced by a mix of milestone euphoria surrounding nuclear design approvals and anxiety over the company's pre-revenue financial status. Market participants are intensely debating the stock's volatility ahead of earnings, tracking heavy options activity and insider trading patterns while weighing the company's long-term potential as a power source for AI infrastructure against the reality of its speculative business model.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to a major hyperscale customer order for 1.6T data center transceivers, fueling intense speculation about the company's role in future AI infrastructure. While bulls are celebrating strong momentum and aggressive price target upgrades, the community remains deeply divided, with bears pointing to massive insider selling and historical volatility as signs of an impending correction.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors monitor the upcoming deadline for a potential proxy fight involving major shareholder Shah Capital, while simultaneously tracking key institutional conferences and high short interest. The community is actively debating the impact of upcoming data, the potential for new high-value licensing partnerships, and the stock's positioning against struggling mRNA competitors.

Elbit Systems Ltd. engages in the defense and homeland security sector. It develops and supplies airborne, land and naval systems and products for defense, homeland security, and commercial applications. The firm also provides training and support services. The company was founded in 1996 and is headquartered in Haifa, Israel.

Elbit Systems Ltd.

Elbit Systems is trending as investors monitor ongoing contract wins in the global defense sector, while community discussions focus on its technical performance and valuation compared to industry peers. Market participants are also weighing the impact of its recent dividend increase and elevated demand for military technologies against a backdrop of regional geopolitical volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) continues to see massive volatility as investors weigh the rapid adoption of USDC against institutional insider selling and competitive threats in the stablecoin market. The community remains deeply divided, with bulls pointing to growing transaction volumes and strategic partnerships, while vocal bears argue that the stock's recent parabolic rise is a detached, synthetic rally prone to a sharp reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aktis Oncology (NASDAQ:AKTS) Stock Price Up 7.2% - Here's What Happened

Aktis Oncology (NASDAQ:AKTS) Trading 7.2% Higher - Should You Buy...

Aktis Oncology Unveils Miniprotein Radiopharma Platform, Highlights Nectin-4 and B7-H3 Programs

Aktis Oncology (NASDAQ:AKTS) executives outlined the company's strategy to expand the use of targeted radiopharmaceuticals beyond the limited set of currently approved products, emphasizing a novel...

HC Wainwright Begins Coverage on Aktis Oncology (NASDAQ:AKTS)

HC Wainwright started coverage on shares of Aktis Oncology in a research report on Monday. They issued a "buy" rating and a $30.00 price target for the company...

Aktis Oncology Details Radiopharma Expansion, Fast Track Win for AKY-1189 at TD Cowen Conference

Aktis Oncology (NASDAQ:AKTS) used a presentation at TD Cowen's 46th Annual Healthcare Conference to outline its strategy to broaden the reach of targeted radiopharmaceutical therapy beyond today's...

Aktis Oncology's Quiet Period Set To End on February 18th (NASDAQ:AKTS)

Aktis Oncology's (NASDAQ:AKTS - Get Free Report) quiet period is set to expire on Wednesday, February 18th. Aktis Oncology had issued 17,650,000 shares in its public offering on January 9th. The...

Aktis Oncology (NASDAQ:AKTS) Coverage Initiated at TD Cowen

TD Cowen started coverage on shares of Aktis Oncology in a report on Tuesday. They issued a "buy" rating for the company...

Aktis Oncology (NASDAQ:AKTS) Now Covered by Bank of America

Bank of America began coverage on Aktis Oncology in a research report on Tuesday. They issued a "buy" rating and a $34.00 price target on the stock...

Aktis Oncology (NASDAQ:AKTS) Now Covered by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on Aktis Oncology in a research note on Tuesday. They issued an "overweight" rating and a $30.00 target price on the stock...

Aktis Oncology (NASDAQ:AKTS) Earns Outperform Rating from Analysts at Leerink Partners

Leerink Partners assumed coverage on shares of Aktis Oncology in a report on Tuesday. They set an "outperform" rating and a $31.00 price objective on the stock...

Aktis Oncology (NASDAQ:AKTS) Shares Down 7.1% - Here's What Happened

Aktis Oncology (NASDAQ:AKTS) Stock Price Down 7.1% - Here's Why...

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.

Current Price	$19.69
Prev Close	$19.77
Open	$19.51
Dividend Yield	N/A
50-Day Moving Average	$19.38
Beta	0.00
Avg. Volume	231,207.17
PE Ratio	N/A

52-Week High	$29.16
52-Week Low	$0.0372
Market Capitalization	$1.05B
EPS (Annual)	-$0.8374
Price to Book	-11.83
Revenue Per Employee	N/A

AKTS
Akoustis Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AKTS News

AKTSAkoustis Technologies Inc